Tag: tumor immunology
-
New Nanoparticles Stimulate the Immune System to Attack Ovarian Tumors
Reframing Immunotherapy for Ovarian Cancer Immunotherapy has transformed cancer treatment by empowering the body’s own defender — the immune system — to recognize and destroy tumor cells. Yet ovarian cancer has proved streaky ground for many immunotherapies, with tumors often adept at cloaking themselves from immune detection. Recent advances, however, suggest that nanoscale delivery systems…
-
Nanoparticles Boost Immune Attack on Ovarian Tumors
New nanoparticle approach aims to strengthen immunotherapy for ovarian cancer Cancer immunotherapy has transformed treatment for several tumor types, but its success with ovarian cancer has been limited. Recent research explores a novel class of nanoparticles designed to prime the immune system and improve anti-tumor responses specifically in ovarian tumors. By delivering immune-stimulating signals directly…
-
Unraveling Tumor-associated Adaptive NK Cells: A Doctoral Disputation by Yizhe Sun
Overview of the disputation The doctoral disputation by Yizhe Sun, held on October 24, 2025, at Karolinska Institutet in Stockholm, marks a significant milestone in tumor immunology. The examination, supervised by senior and junior mentors from Karolinska Institutet and collaborating institutions, centers on the phenotypic features and functional mechanisms of tumor-associated adaptive natural killer (NK)…
-
Disputation: Unraveling Tumor-Associated Adaptive Natural Killer Cells
Overview of the disputation The upcoming disputation at Karolinska Institutet centers on a critical topic in tumor immunology: unraveling the phenotypic features and functional mechanisms of tumor-associated adaptive natural killer (NK) cells. Held on 2025-10-24 from 8:30 to 13:30, the event invites a clinical and research audience to engage with cutting-edge insights into how adaptive…
-
Glioblastoma Study Reveals Skull Erosion and Immune Shifts
Groundbreaking finding: glioblastoma interacts with the skull and immune marrow Scientists from Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have shown, for the first time, that glioblastoma—one of the deadliest brain cancers—does more than invade brain tissue. The disease also erodes the skull, alters the makeup of skull marrow,…